Erratum: Mohty M, Malard F, Blaise D, Milpied N, Furst S, Tabrizi R, Guillaume T, Vigouroux S, El-Cheikh J, Delaunay J, Le Gouill S, Moreau P, Labopin M and Chevallier P. Reduced-toxicity conditioning with fludarabine, once-daily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: Results of a multicenter prospective phase 2 trial. Cancer. doi: 10.1002/cncr.29087.
In Table 1, the numbers for NHL should be 20(25%). In the legend for Figure 1, part (B) should read chronic GVHD is shown. The authors regret these errors.